Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

• Príomhchruthaitheoirí: Chen-Qian Liu (Údar), Jian-Xuan Sun (Údar), Jin-Zhou Xu (Údar), Xiao-Yuan Qian (Údar), Sen-Yuan Hong (Údar), Meng-Yao Xu (Údar), Ye An (Údar), Qi-Dong Xia (Údar), Jia Hu (Údar), Shao-Gang Wang (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: The incidence rate and mortality of bladder cancer are increasing year by year. Interestingly, the commonly used metabolic regulatory drug metformin has been reported to have anti-tumor effect in recent years. Nevertheless, it keeps unclear whether the usage of metformin is beneficial or...